Merck wipes Serono off Swiss biotech map

Article Abstract:

Merck KGaA, a Daramstadt-based German company, has acquired Geneva-based Serono for 13.2 billion dollar. The company claims that by taking this decision it has achieved three of the five objectives set for itself to foster growth and remain independent, namely achieving competitive scale in R&D, adding new therapeutic treatment in specialist areas and expanding its geographical reach into the US.

Acquisitions & mergers, CHEMICALS AND ALLIED PRODUCTS, Germany, Mergers, acquisitions and divestments, Company acquisition/merger, Switzerland, Chemical industry, Merck KGAA, Pesticides industry, Herbicides, Serono AG, Sulphur industry

---

My worst biotech investment

Article Abstract:

The drug maker QLT was a huge success in the fall of 2004 with its proprietary photodynamic drug Visudyne, the leading treatment for wet age-related macular degeneration. However it failed in meeting the expected profit and endured a loss of 38%.

United States, Market share, Growth, Cancer, Company market share, Photochemotherapy, Visudyne (Medication), QLT Inc., Company growth

---

Antivirals - an increasingly healthy investment

Article Abstract:

The four important trends in the antiviral markets such as new mechanisms, second-generation molecules, combination treatments and unique administration routes are discussed.

Forecasts, trends, outlooks, Science & research, Research, Usage, Forecasts and trends, Market trend/market analysis, Antiviral agents

Similar abstracts:

• Abstracts: Streptococcal genomes provide food for thought. Protecting your investment. The best of both worlds in plant protection
• Abstracts: Ergonomic design interventions - a case study involving portable ladders. Improving digital human modelling for proactive ergonomics in design
• Abstracts: Staging of venture financing, investor opportunism and patent law. A value-of-information approach to measuring risk in multi-period economic activity
• Abstracts: Payback without apology. Are there nonlinearities in short-term interest rates? Market reaction to takeover rumour in Internet discussion sites

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.